IMPROVE 2022

Tuesday, 11 October 2022, Berlin

International Meeting on Pathway-Related Obesity: Vision of Excellence 2022.

.

Revisit the inaugural IMPROVE meeting which took place in October 2022. Professor Peter Kühnen (Chair) and Professor Martin Wabitsch (Co-chair) were joined by expert faculty from across the globe to deliver talks covering the latest scientific developments and appropriate patient care in the field of rare melanocortin-4 receptor (MC4R) pathway diseases, in which genetic deficiency can result in hyperphagia and early onset obesity.

Please login or signup to unlock the videos.

Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.

LoginSignup

It could have been so simple: how single-cell-analysis is changing our paradigms

Professor Yeo outlines how single cell approaches have been used to unravel the complexity of the architecture and function of the different cell types within the hypothalamus and discusses how this work is being used.

Scientific Steering Committee:

Prof Peter Kühnen

(Germany)

Prof. Martin Wabitsch

(Germany)

Professor Sadaf Farooqi

(UK)

Prof Antje Körner

(Germany)

Prof. Karine Clément

(France)

Prof Hélène Dollfus

(France)

Prof Jesús Argente

(Spain)